References
- Benveniste J. Biosynthesis and Function of PAF-Acether (Platelet-Activating Factor). Advances in Prostglandin, Thromboxane, and Leukotrien Research, S. Hayashi, Yamamoto. Raven Press, New York 1985; Vol. 15: 689–691
- Braquet P. The Ginkgolides: Potent Platelet-Activating Factor Antagonists Isolated from Ginkgo Biloha L.: Chemistry, Pharmacology and Clinical Applications. Drugs of the Future 1987; 12: 643–699
- Braquet P., Yidal R. F., Braquet M., Hamard H., Vargaftig B. B. Involvement of leu-kotrienes and PAF-acether in the increased microvascular permeability of the rabbit retina. Agents and Actions 1988; 15: 82–85
- Doly M., Bonhomme B., Braquet P., Chabrier P. E., Meyniel G. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. Immunopharmacol. 1987; 13: 189–194
- Verbeij N. L., van Delft J. L., van Haeringen N. J., Braquet P. Platelet-activating factor and laser trauma of the iris, in preparation
- Yousufzai S. Y.K., Abdel-Latif A. A. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Biochem. J. 1985; 228: 697–706
- Hwang S. B., Lee C-S, C, Cheah M. J., Shen T. Y. Specific Receptor Sites for 1-0-Alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (Platelet Activating Factor) on Rabbit Platelet and Guinea Pig Smooth Muscle Membranes. Biochem. 1983; 22: 4756–4763
- Hwang S. B., Lam M. H. Species difference in the specific receptor of platelet activating factor. Biochem. Pharmacol. 1986; 35: 4511–4518
- Hwang S. B. Specific Receptor Sites for Platelet Activating Factor on Rat Liver Plasma Membranes. Arch. Biochem. Biophys. 1987; 257: 339–344
- Domingo M. T., Spinnewyn B., Chabrier P. P., Braquet P. Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem. Biophys. Res. Comm 1988, (accepted for publication)
- Braquet P., Godfroid J. J. PAF-acether specific binding sites: 2, Design of specific antagonists. TIPS October, 1986; 1986: 397–403
- Braquet P., Etienne A., Touvay C, Bour-gain R. H., Lefort J., Vargaftig B. B. Involvement of platelet activating factor in respiratory anaphylaxis demonstrated by PAF-acether inhibitor BN 52021. The Lancet, June 1935; 29: 1501
- Domingo M. T., Chabrier P. E., Dray F. Inhibition by Ginkgolides of the binding of 3H-PAF platelet activating factor (PAF) to platelet membranes. “Ginkgolides-Chemistry, Biology, Pharmacology and Clinical Perspectives—.”, P. Braquet. J.R. Prous Science Publ., Barcelona 1938; vol. 1: 79–84
- Verbeij H. L.J., van Haeringen N. J. Interference of a Ginkgolide with models of corneal diseases. “Ginkgolides-Chemistry, Biology, Pharmacology and Clinical Perspectives”, P. Braquet. J.R. Prous Science Publ., Barcelona 1987; 749–757
- Vindimian E., Robaut C, Pillion G. A Method for Cooperative or Honcooperative Binding Studies Using Nonlinear Regression Analysis on a Microcomputer. J. App. Biochem 1983; 5: 261–268
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254